Qilu hospital of shandong university
Jinan, Shandong, 250012, China
NCT Number: NCT06895772
The characteristics of the intestinal microbiota in Crohn's disease and their relationship with disease pathogenesis have not yet been fully elucidated. Therefore, this study aims to analyze the microbial community characteristics in the intestinal mucosal tissue of Crohn's disease patients and fill this knowledge gap. Additionally, this research holds significant importance for understanding the etiology of Crohn's disease and predicting treatment outcomes.
This study is active but is not currently recruiting participants.
Notify Me18 year–80 year
All sexes
Observational
Jinan, Shandong, 250012, China
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 12 months
Analyze the characteristics of the microbiota within the intestinal mucosal tissue of patients with Crohn's disease;Analyze the differences in the microbiota between the lesional and normal intestinal mucosal tissues of patients with Crohn's disease;Analyze the differences in the microbiota within the intestinal mucosal tissue of patients with Crohn's disease before and after treatment.
Time frame: 12 months
Compare the differences in the microbiota within the intestinal mucosal tissue between patients with Crohn's disease and healthy individuals
Shandong University
Other
Analysis of Microbial Community Characteristics in Intestinal Mucosal Tissue of Patients With Crohn's Disease
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06922331
Colitis, Colitis, Ulcerative
Guangzhou, Guangdong, China
View Trial DetailsNCT06770140
Crohn's Disease (CD)
Rotterdam, South Holland, Netherlands
View Trial DetailsNCT01793831
Crohn's Disease (CD), Digestive System Diseases
Huai'an, Jiangsu, China
View Trial Details